Open AccessAxitinib Shows Clinical Utility in Heavily Pretreated Kidney Cancer Patients
Author(s) -
Rabiya S. Tuma
Publication year - 2007
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000303241.71438.68
Subject(s) - sorafenib , sunitinib , medicine , axitinib , temsirolimus , cancer , oncology , kidney cancer , renal cell carcinoma , clinical endpoint , refractory (planetary science) , clinical trial , discovery and development of mtor inhibitors , pi3k/akt/mtor pathway , hepatocellular carcinoma , apoptosis , biochemistry , chemistry , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom